Fintel reports that on November 3, 2025, BMO Capital upgraded their outlook for Replimune Group (NasdaqGS:REPL) from Underperform to Market Perform.
Analyst Price Forecast Suggests 11.38% Upside
As of October 30, 2025, the average one-year price target for Replimune Group is $10.84/share. The forecasts range from a low of $2.02 to a high of $23.10. The average price target represents an increase of 11.38% from its latest reported closing price of $9.73 / share.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for Replimune Group is 303MM. The projected annual non-GAAP EPS is -2.63.
What is the Fund Sentiment?
There are 361 funds or institutions reporting positions in Replimune Group. This is an increase of 8 owner(s) or 2.27% in the last quarter. Average portfolio weight of all funds dedicated to REPL is 0.19%, an increase of 9.71%. Total shares owned by institutions decreased in the last three months by 2.35% to 87,848K shares. 
The put/call ratio of REPL is 0.46, indicating a bullish outlook.
What are Other Shareholders Doing?
Baker Bros. Advisors holds 11,045K shares representing 14.15% ownership of the company. No change in the last quarter.
Price T Rowe Associates holds 10,819K shares representing 13.86% ownership of the company. In its prior filing, the firm reported owning 10,854K shares , representing a decrease of 0.32%. The firm decreased its portfolio allocation in REPL by 12.68% over the last quarter.
Redmile Group holds 4,665K shares representing 5.98% ownership of the company. In its prior filing, the firm reported owning 4,899K shares , representing a decrease of 5.01%. The firm increased its portfolio allocation in REPL by 2.17% over the last quarter.
PRNHX - T. Rowe Price New Horizons Fund holds 4,214K shares representing 5.40% ownership of the company. In its prior filing, the firm reported owning 4,666K shares , representing a decrease of 10.71%. The firm decreased its portfolio allocation in REPL by 7.65% over the last quarter.
Fcpm Iii Services B.v. holds 3,910K shares representing 5.01% ownership of the company. No change in the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
